Back |
home / stock / ubx / ubx message board
Subject | By | Source | When |
---|---|---|---|
Only 14m shares now, 24m traded today lol.. $UBX$... | Pisd | investorshub | 11/01/2022 4:32:24 PM |
Buyer of sell-the-news a bargain at $3 imo.. $UBX$... | Pisd | investorshub | 11/01/2022 2:34:06 PM |
.The word on The Street in general, suggests | surfkast | investorshub | 10/13/2022 8:13:14 PM |
.The word on The Street in general, suggests | surfkast | investorshub | 10/13/2022 8:13:08 PM |
Need more buying! | surfkast | investorshub | 10/11/2022 9:41:30 PM |
$UBX loading heavy !!! | TradeNaked | investorshub | 10/11/2022 5:18:28 PM |
Crawling back up? | surfkast | investorshub | 10/03/2022 5:05:14 PM |
Wedbush Remains a Buy on Unity Biotechnology ($UBX) | surfkast | investorshub | 09/26/2022 11:48:40 PM |
This needs new buyers to outpace the employees | surfkast | investorshub | 09/23/2022 3:43:26 PM |
I think it has massive potential. Many catalysts | TradeNaked | investorshub | 09/23/2022 3:20:34 PM |
Nice. I am in higher. But if it | surfkast | investorshub | 09/23/2022 2:43:14 PM |
$UBX this will launch soon me thinks | TradeNaked | investorshub | 09/23/2022 2:17:16 PM |
znewcar1: UBX 54% v93,9M c1.31 f69,2M H1.85 ML.58 LL.55 | znewcar1 | investorshangout | 08/12/2022 8:17:18 PM |
News, Short Squeeze, Breakout and More Instantly...
Unity Biotechnology Inc. Company Name:
UBX Stock Symbol:
NASDAQ Market:
Unity Biotechnology Inc. Website:
SOUTH SAN FRANCISCO, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the first quarter ended March 31, 2024. "Our team r...
SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that the Company will present two poster presentations at t...
SOUTH SAN FRANCISCO, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that the ongoing Phase 2b ASPIRE study of UBX1325 has been e...